Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Evogen Wins $224K SBIR Grant for Epilepsy Dx Development

Evogen Wins $224K SBIR Grant for Epilepsy Dx Development

Apr 10, 2019
|
staff reporter

NEW YORK (360Dx) — Evogen announced today that it has received a $224,515 grant from the National Institutes of Health to continue development of a protein biomarker-based diagnostic for epilepsy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Immunoassays

  1. BioMérieux Reports 62 Percent BioFire FilmArray Sales Growth in Preliminary Q2 Release

  2. LGC Acquires UK Infectious Disease Firm to Expand Reagent Portfolio

  3. Diazyme Receives Emergency Use Authorization for Coronavirus Antibody Test

  4. One of Four Coronavirus Antibody Tests Met UK Agency's Sensitivity Criteria in Head-to-Head Study

  5. BD Rapid Coronavirus Antigen Test Gets FDA Emergency Use Authorization

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.